SCHEDULE 13G/A: Deerfield Entities Amend Stake in Alignment Healthcare, Disclosing 3.81% Beneficial Ownership

Sentiment:

Beneficial Ownership Report Amendment


Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have jointly filed an amended Schedule 13G, reporting a collective beneficial ownership of 3.81% in Alignment Healthcare, Inc.'s Common Stock as of December 31, 2024.

Summary

  • Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Alignment Healthcare, Inc.
  • The reporting persons collectively beneficially own 7,304,302 shares of Alignment Healthcare, Inc. Common Stock.
  • This aggregate amount represents 3.81% of the class of Common Stock.
  • The filing indicates shared voting and dispositive power over all 7,304,302 shares among the reporting persons.
  • The reporting persons, all based in Delaware (except James E. Flynn, a U.S. citizen), operate from 345 Park Avenue South, 12th Floor, New York, NY 10010.
  • The filing states that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a routine disclosure by an institutional investor group, Deerfield Management, regarding their passive ownership stake in Alignment Healthcare, Inc., a company operating in the healthcare sector. It does not provide specific insights into broader industry trends or competitive dynamics beyond confirming Deerfield's continued investment in the space.

Stakeholder Impact

  • Shareholders: Provides transparency regarding the ownership stake held by a significant institutional investor group, Deerfield Management, which can influence market perception and trading activity.

Key Dates

DateDescription
12/31/2024Date of event which requires filing of this statement (reporting period end date for beneficial ownership).
02/13/2025Date of filing of the Schedule 13G/A amendment.

Keywords

Alignment Healthcare Inc., Deerfield Management, Schedule 13G/A, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Healthcare Investment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.